The overexpression of LSD1 is observed in different types of malignancies, such as colorectal, breast, prostate, small cell lung cancer (SCLC), and acute myeloid leukemia (AML), exerting a tumor-promoting activity28. Here, KDM1A is linked to acute myeloid leukemia.